宫颈脱落细胞microRNA-508-3p、ROCK1的表达及其对宫颈癌的诊断价值研究
作者:
作者单位:

诸暨市人民医院 病理科,浙江 诸暨 311800

中图分类号:

R737.33

基金项目:

浙江省医学会临床科研基金(No:2019ZYC-A159)


Expression of microRNA-508-3p and ROCK1 in exfoliated cervical cells and their diagnostic values in cervical cancer
Author:
Affiliation:

Department of Pathology, Zhuji People's Hospital, Zhuji, Zhejiang 311800, China

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献 [24]
  • |
  • 相似文献 [20]
  • | | |
  • 文章评论
    摘要:

    目的 探究宫颈脱落细胞microRNA-508-3p(miR-508-3p)、ROCK1的表达及其对宫颈癌的诊断价值。方法 选取2016年2月—2019年9月诸暨市人民医院收集的宫颈脱落细胞标本172例,其中正常组70例、宫颈上皮内瘤变组54例、宫颈癌组48例。通过qRT-PCR、免疫组织化学、Western blotting检测各组细胞miR-508-3p、ROCK1的表达,荧光素酶报告实验验证宫颈病变脱落细胞miR-508-3p与ROCK1的相关性,观察宫颈癌脱落细胞miR-508-3p、ROCK1表达与宫颈癌患者临床资料的关系,通过受试者工作特征(ROC)曲线评估宫颈病变脱落细胞miR-508-3p、ROCK1表达对宫颈病变的诊断价值。结果 与正常组比较,宫颈癌组和宫颈上皮内瘤变组miR-508-3p降低(P <0.05),ROCK1 mRNA、ROCK1 mRNA阳性率、ROCK1蛋白相对表达量升高(P <0.05);与宫颈上皮内瘤变组比较,宫颈癌组miR-508-3p降低,ROCK1 mRNA、ROCK1 mRNA阳性率、ROCK1蛋白相对表达量升高(P <0.05)。宫颈癌组、宫颈上皮内瘤变组miR-508-3p与ROCK1 mRNA呈负相关(r =-0.6678和-0.5234,均P =0.000),ROCK1是miR-508-3p的直接靶基因。miR-508-3p、ROCK1水平与宫颈癌患者FIGO分期、淋巴结转移有关(P <0.05),与年龄、绝经情况、肿瘤直径及病理类型无关(P >0.05)。在诊断宫颈癌和宫颈上皮内瘤变时,miR-508-3p的ROC曲线下面积(AUC)分别为0.946(95% CI:0.899,0.993)和0.851(95% CI:0.782,0.921),敏感性为87.1%(95% CI:0.776,1.654)和84.3%(95% CI:0.746,1.589),特异性为100.0%(95% CI:1.000,2.000)和79.6%(95% CI:0.702,1.497);ROCK1的AUC分别为0.949(95% CI:0.892,1.000)和0.905(95% CI:0.852,0.958),敏感性为89.6%(95% CI:0.810,1.706)和77.8(95% CI:0.667,1.445),特异性为100.0%(95% CI:1.000,2.000)和88.6%(95% CI:0.812,1.698)。随访1年后,48例宫颈癌患者中生存42例,死亡6例。生存组miR-508-3p高于死亡组(P <0.05),ROCK1 mRNA相对表达量低于死亡组(P <0.05)。结论 宫颈脱落细胞miR-508-3p、ROCK1在宫颈癌患者中表达异常,其中miR-508-3p下调,ROCK1上调,两者呈靶向负调控关系,并与宫颈癌患者FIGO分期及淋巴结转移密切相关,具有一定的宫颈癌诊断价值,可作为早期宫颈癌筛查的潜在生物学指标。

    Abstract:

    Objective To investigate the expression of microRNA-508-3p (miR-508-3p) and Rho-associated protein kinase 1 (ROCK1) in exfoliated cervical cells and their diagnostic values in cervical cancer.Methods From February 2016 to September 2019, 172 cases of exfoliated cervical cells were collected in our hospital, including 70 cases in the normal group, 54 cases in the cervical intraepithelial neoplasia group, and 48 cases in the cervical cancer group. The expression of miR-508-3p and ROCK1 in each group was detected by qRT-PCR, immunohistochemistry, and Western blotting. Luciferase assay was used to verify the interaction between miR-508-3p and ROCK1 in the exfoliated cervical cells. The relationship between the expression of miR-508-3p and ROCK1 in the exfoliated cervical cells and the clinical data of cervical cancer patients were analyzed, and the diagnostic value of miR-508-3p and ROCK1 expression in the exfoliated cervical cells was evaluated via receiver operating characteristic (ROC) curve.Results Compared with the normal group, the content of miR-508-3p in cervical cancer group (P < 0.05) and cervical intraepithelial neoplasia group (P < 0.05) was decreased, while ROCK1 mRNA level, the positive rate of ROCK1 mRNA and ROCK1 protein content were increased (P < 0.05). Compared with the cervical intraepithelial neoplasia group, the content of miR-508-3p in the cervical cancer group was decreased (P < 0.05), while ROCK1 mRNA level, the positive rate of ROCK1 mRNA and ROCK1 protein content were increased (P < 0.05). MiR-508-3p was negatively correlated with ROCK1 in the cervical cancer group (r = -0.6678, P = 0.000) and the cervical intraepithelial neoplasia group (r =-0.5234, P = 0.000), and ROCK1 was the direct target gene of miR-508-3p. The relative expression levels of miR-508-3p and ROCK1 were correlated with FIGO stage and lymph node metastasis of cervical cancer (P < 0.05), but not with age and menopausal status of patients, or diameter and pathological type of tumor (P > 0.05). In the diagnosis of cervical cancer and cervical intraepithelial neoplasia, the area under the ROC curve (AUC) of miR-508-3p was 0.946 (95% CI: 0.899, 0.993) and 0.851 (95% CI: 0.782, 0.921), the sensitivity was 87.1% (95% CI: 0.776, 1.654) and 84.3% (0.746, 1.589), and the specificity was 100.0% (1.000, 2.000) and 79.6% (95% CI: 0.702, 1.497), respectively. The AUC of ROCK1 was 0.949 (95% CI: 0.892, 1.000) and 0.905 (95% CI: 0.852, 0.958), the sensitivity was 89.6% (95% CI: 0.810, 1.706) and 77.8% (95% CI: 0.667, 1.445), and specificity was 100.0% (95% CI: 1.000, 2.000) and 88.6% (95% CI: 0.812, 1.698), respectively. After 1-year follow-up, 42 cases survived and 6 cases died in 48 cases of cervical cancer. The expression level of miR-508-3p in the survival group was higher than that in the death group, and the expression level of ROCK1 mRNA in the survival group was lower than that in the death group (P < 0.05).Conclusions The expression of miR-508-3p and ROCK1 in exfoliated cervical cells of patients with cervical cancer is severely abnormal, in which miR-508-3p is downregulated while ROCK1 is upregulated. The miR-508-3p targets ROCK1 and negatively regulates ROCK1, and both of them are closely associated with the pathological staging and lymph node metastasis in cervical cancer patients. Besides, they are of diagnostic value and may be potential biomarkers for cervical cancer screening.

    表 3 各临床病理特征宫颈癌患者miR-508-3p和ROCK1表达水平比较 [n =24, 例(%)]Table 3
    表 1 qRT-PCR引物序列Table 1
    表 2 各组宫颈脱落细胞miR-508-3p、ROCK1比较Table 2
    表 4 miR-508-3p、ROCK1诊断宫颈癌和宫颈上皮内瘤变的ROC曲线参数Table 4
    表 5 生存组与死亡组脱落细胞miR-508-3p、ROCK1 mRNA相对表达量比较Table 5
    图1 各组宫颈脱落细胞中ROCK1的表达 (免疫组织化学×200)Fig.1
    图2 各组宫颈脱落细胞ROCK1蛋白的表达Fig.2
    图3 宫颈癌组miR-508-3p与ROCK1 mRNA的相关性散点图Fig.3
    图4 宫颈上皮内瘤变组miR-508-3p与ROCK1 mRNA的相关性散点图Fig.4
    图5 Targetscan网站预测miR-508-3p与ROCK1的靶向关系Fig.5
    参考文献
    [1] JONAH M, ACHENBACH C J, O'DWYER L C, et al. Effect of cervical cancer education and provider recommendation for screening on screening rates: a systematic review and meta-analysis[J]. PLoS One, 2017, 12(9): e0183924.
    [2] PIMPLE S A, MISHRA G A. Global strategies for cervical cancer prevention and screening[J]. Minerva Ginecol, 2019, 71(4): 313-320.
    [3] BHATLA N, SINGHAL S. Primary HPV screening for cervical cancer[J]. Best Pract Res Clin Obstet Gynaecol, 2020, 65(5): 98-108.
    [4] TIAN Q F, LI Y, WANG F F, et al. MicroRNA detection in cervical exfoliated cells as a triage for human papillomavirus-positive women[J]. J Natl Cancer Inst, 2014, 10(9): 1-8.
    [5] PARDINI B, DANIELA D M, FRANCAVILLA A, et al. MicroRNAs as markers of progression in cervical cancer: a systematic review[J]. BMC Cancer, 2018, 18(1): 696.
    [6] HU P, ZHOU G J, ZHANG X H, et al. Long non-coding RNA Linc00483 accelerated tumorigenesis of cervical cancer by regulating miR-508-3p/RGS17 axis[J]. Life Sci, 2019, 234(2): 116789.
    [7] 秦海霞, 李少平, 朱利红, 等. miR-335调控ROCK1对宫颈癌细胞作用的研究[J]. 中国妇产科临床杂志, 2018, 19(5): 407-410.
    [8] 中华人民共和国国家卫生和计划生育委员会. 宫颈癌及癌前病变规范化诊疗指南(试行)[J]. 中国医学前沿杂志(电子版), 2013, 5(8): 37-46.
    [9] 梁登辉, 高原, 舒丽莎. 宫颈脱落细胞中cyclin、Ki67的表达对宫颈癌高危人群筛查的意义及其管理对策分析[J]. 中国性科学, 2020, 29(7): 29-32.
    [10] CUBIE H A, CAMPBELL C. Cervical cancer screening-the challenges of complete pathways of care in low-income countries: focus on malawi[J]. Womens Health (Lond), 2020, 16(10): 1745506520914804.
    [11] 张建芝. 江苏省南通市通州区农村妇女宫颈癌筛查结果分析[J]. 系统医学, 2018, 3(15): 116-117.
    [12] HASANZADEH M, MOVAHEDI M, REJALI M, et al. The potential prognostic and therapeutic application of tissue and circulating microRNAs in cervical cancer[J]. J Cell Physiol, 2019, 234(2): 1289-1294.
    [13] AHADI A. The significance of microRNA deregulation in colorectal cancer development and the clinical uses as a diagnostic and prognostic biomarker and therapeutic agent[J]. Noncoding RNA Res, 2020, 5(3): 125-134.
    [14] 方红艳, 汪锋平, 张善征. 血清miR-10a、IL-35水平在脓毒症并发急性肾损伤的诊断的临床分析[J]. 浙江创伤外科, 2020, 25(4): 728-730.
    [15] PEREIRA J D, TOSATTI J A G, SIM?ES R, et al. micrornas associated to anthracycline-induced cardiotoxicity in women with breast cancer: a systematic review and pathway analysis[J]. Biomed Pharmacother, 2020, 131: 110709.
    [16] 杨希, 朱君飞, 吴旭佳, 等. 非小细胞肺癌miR-155和FoxO1表达临床意义[J]. 中华肿瘤防治杂志, 2018, 25(10): 713-716.
    [17] WANG Z Z, JIN J J. LncRNA SLCO4A1-AS1 promotes colorectal cancer cell proliferation by enhancing autophagy via miR-508-3p/PARD3 axis[J]. Aging (Albany NY), 2019, 11(14): 4876-4889.
    [18] GUO S J, ZENG H X, HUANG P, et al. miR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer[J]. Eur Rev Med Pharmacol Sci, 2018, 22(19): 6379-6385.
    [19] HUANG T T, KANG W, ZHANG B, et al. miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis[J]. Mol Cancer, 2016, 15(1): 9.
    [20] HU C B, LI Q L, HU J F, et al. miR-124 Inhibits growth and invasion of gastric cancer by targeting ROCK1[J]. Asian Pacific Journal of Cancer Prevention Apjcp, 2014, 15(16): 6543-6546.
    [21] 程甜甜, 杨贤子, 骆志国. Axl及其配体Gas6在宫颈鳞癌中的表达与意义[J]. 川北医学院学报, 2016, 31(2): 228-231.
    [22] LEUNG CARMEN O N, DENG W, YE T M, et al. MicroRNA-135a-induced formation of CD133+ subpopulation with cancer stem cell properties in cervical cancer[J]. Carcinogenesis, 2020, 41(11): 1592-1604.
    [23] SATAPATHY S, BATRA J, JEET V, et al. MicroRNAs in HPV associated cancers: small players with big consequences[J]. Expert Rev Mol Diagn, 2017, 17(7): 711-722.
    [24] MIN X H, ZHANG M S, HUANG F J, et al. Live cell microrna imaging using exonuclease Ⅲ-aided recycling amplification based on aggregation-induced emission luminogens[J]. ACS Appl Mater Interfaces, 2016, 8(14): 8998-9003.
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

何立群,袁婧,张舒云.宫颈脱落细胞microRNA-508-3p、ROCK1的表达及其对宫颈癌的诊断价值研究[J].中国现代医学杂志,2021,(16):28-35

复制
分享
文章指标
  • 点击次数:309
  • 下载次数: 185
  • HTML阅读次数: 48
  • 引用次数: 0
历史
  • 收稿日期:2021-02-25
  • 在线发布日期: 2023-10-31
文章二维码